Finance News - Immunotherapy

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Immunotherapy

City A.M. • 03/12/2026 • Free

Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)

Baseimmune's strategic expansion into fibrosis and multi-pathway immunotherapies could diversify its pipeline and potentially increase long-term reven...

Read Full Article →

The Guardian – Business • 09/15/2025 • Free

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial

Merck’s decision to close its London research center highlights shifting global investment priorities, as competitive pressures and innovation strateg...

Read Full Article →

Economic Times Markets • 06/06/2025 • Subscription Required

Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar

The partnership between Dr. Reddy’s and Alvotech to develop a biosimilar immunotherapy drug could enhance their positions in the rapidly expanding onc...

Read Full Article →

Price Alerts

Sign in to create alerts

Finance News - Immunotherapy

Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial

Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

Finance News - Immunotherapy

Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial

Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format